General Experimental Details
Starting materials and reagents were purchased from Aldrich, Acros or TCI. Yields refer to analytically pure compounds and have not been optimized. All solvents were reagent-grade and if necessary, dried and distilled prior to use. Reactions were carried out under nitrogen gas atmosphere. Column chromatography was performed on silica gel (Silicycle 
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Experimental procedures
Synthesis of the building blocks:
Compounds (S)-6 and (S)-7 were synthesized according to procedures reported in the literature and their spectroscopic data are in agreement.
1,2
1-Bromo-3-mesitylpropan-2-one (9) (adapted from 1-3 )
In a dry 100-mL three-necked flask, mesitylacetic acid (8) (1 eq., 1.5 g, 8.4 mmol) was dissolved in dry toluene (10 mL). Thionyl chloride (13.8 eq., 8.5 mL, 116 mmol) was added to this reaction mixture, and was refluxed for 3 h. The colorless solution was concentrated in vacuo to obtain a yellow crude oil, which was dissolved in ether (8 mL). This solution was added dropwise to trimethylsilyl-diazomethane in ether (2.6 eq., 10.8 mL, 2 M, 21.7 mmol) at 0-5 °C. The yellow solution was left to stir at room temperature for 1 h followed by the dropwise addition of aqueous HBr (10.8 mL, 47.5%), and the orange emulsion was refluxed for 2.5 h. It was cooled down to room temperature, and the ether layer was separated and washed with water (1 x 50 mL). The aqueous layer was extracted with ether (3 x 35 mL). The combined organic layers were washed with saturated aqueous NaHCO3 solution and water sequentially, dried over MgSO4, filtered and concentrated in vacuo. To an ice cold solution of N-Boc-L-tryptophan (5) (1 eq., 610 mg, 2 mmol) in dry THF (5 mL), 1,1'-carbonyl bis-1H-imidazole (1 eq., 324 mg, 2 mmol) was added. After stirring the solution at room temperature for 2 h, under ice cooling, mesitylethylamine 4 (10) (1 eq., 400 mg, 2 mmol) was added, and the reaction mixture was left to stir at room temperature overnight. This solution was concentrated in vacuo, the residue obtained was dissolved in EtOAc (50 mL), washed with water, 0.1 M HCl, saturated acqueous NaHCO3 solution and with a saturated acqueous NaCl solution sequentially. The organic layer was dried over anhydrous MgSO4, filtered, and concentrated in vacuo to obtain (S)-13. It was monitored by TLC (DCM/ MeOH 98:2, stained with Ninhydrin), showing complete conversion.
GC-MS
The crude was used in the next step without any further purification. Trifluoroacetic acid (16mmol, 21.5 mmol, 1.65 mL) was added to a solution of protected amide compound ((S)-13) from the previous step (1 eq., 1.334 mmol, 600 mg) in dry DCM (6 mL) with ice cooling and left to stir for 5 minutes 1 h at room temperature. After concentrating the reaction mixture in vacuo, chloroform (25 mL) was added to the residue. The organic layer was washed with saturated acqueous NaHCO3 solution (3 x 15 mL) and saturated acqueous NaCl solution (15 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to obtain the final product 2 as white solid, (400 mg, quantitative 
(-) 2,4,6-Trimethylphenethyl L-tryptophanate (3)
N-Boc-L-Tryptophan (5) (1eq., 365.4 mg, 1.2 mmol) was dissolved in anhydrous DCM. 2-Mesitylethanol (11) (1 eq., 197.5 mg, 1.2 mmol,) was added to the reaction followed by a catalytic amount of DMAP (5 mol%, 7.33 mg, 0.06 mmol). The reaction was cooled to 0 ºC, and a solution of N,N'-dicyclohexylcarbodiimide (1.1 eq., 272.3 mg, 1.32 mmol) in anhydrous DCM (10 mL) was added dropwise over 10 min. The reaction was allowed to warm to room temperature and a precipitate was observed after 20 min. The reaction was stirred for further 6 h. The reaction was filtered to remove the N,N'-Dicyclohexylcarbodiimide urea by-product and the solvent removed in-vacuo. The residue was placed onto a column of flash silica gel where the product was eluted with (DCM / EtOAc 1:0 to 9:1). The solvent was removed under reduced pressure to afford the product (S)-14, which was used in the next step without further purification.
The crude product was dissolved in DCM (3 mL), and HCl/diethyl ether (1 M, 15 mL) was added. After stirring at room temperature for 24 h, the resulting white precipitate was collected and washed with ether, to afford the final product (S)-3 as a white solid (279 mg, 60% In a 25-mL round-bottomed flask was dissolved 1-bromo-3-mesitylpropan-2-one (9) (1 eq., 51.4 mg, 0.201 mmol) and N-Boc-L-tryptophan thioamide (7) (1.5 eq., 96.3 mg, 0.302 mmol) in absolute ethanol (6 mL). The yellow reaction mixture was heated to reflux for 4 h, and conversion was monitored by TLC (EtOAc/pentane, 3:7). The reaction mixture was concentrated in vacuo, and the crude material was dissolved in a mixture of water and DCM. The organic layer was separated, and the aqueous layer was extracted with DCM (3 x 15 mL). The combined organic layers were collected, dried over MgSO4, filtered and concentrated in vacuo to afford the crude, which was purified by column chromatography (SiO2, EtOAc/pentane, 3:7) to yield (S)-12 (0.072 mmol, 34.1 mg, 36%) as a white solid, which was used in the next step without further purification.
In a 25-mL round-bottomed flask, was dissolved (S)-12 (1 eq., 26.1 mg, 0.055 mmol) in dry DCM (1 mL). The reaction mixture was cooled to 0 °C, and trifluoroacetic acid (TFA) (16 eq., 0.067 mL, 0.878 mmol) was added. The solution was stirred in an ice bath for 5 min and at room temperature for 1 h. The reaction mixture was concentrated in vacuo, and the crude was dissolved in chloroform. The organic layer was washed with saturated aqueous NaHCO3 solution and saturated aqueous NaCl solution, dried over MgSO4, filtered and concentrated in vacuo. The crude was purified by column chromatography (SiO2, EtOAc/pentane, 1:1 " 1:0) to yield (S)-4 (0.031 mmol, 11.5 mg, 56%) as a yellow-orange semisolid. 
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Modeling and Docking:
The X-ray crystal structure of the complex of acylhydrazone (S)-1 with endothiapepsin (PDB code: 4KUP) was used for our modeling. 6 Several ligands were designed in order to mimic the acylhydrazone interactions with the protein whilst finding replacements of the acylhydrazone linker, using the computer program MOLOC. 7 The energy of the system was minimized using the MAB force field as implemented in MOLOC, whilst keeping the protein coordinates fixed. Several acylhydrazone-mimetics were designed and subsequent energy minimization (MAB force field) was done using MOLOC. All types of interactions (hydrogen bonds and lipophilic interactions) between designed acylhydrazones and protein were measured in MOLOC. All the designed bioisosteres of acylhydrazones were subsequently docked into the active site of endothiapepsin by using the FlexX docking module in the LeadIT suite. 8 During the docking, the binding site in the protein was restricted to 9 Å around the bound ligand and the 30 top (FlexX)-scored solutions were retained, and subsequently post-scored with the HYDE 9 module in LeadIT v.2.1.3. After careful visualization to exclude poses with significant inter-or intramolecular clash terms or unfavorable conformations, the resulting solutions were subsequently ranked according to their binding energies. The top-ranked solutions identified in this way were included in the bioisostere library. In all cases, the designed acylhydrazonemimetics address the catalytic dyad directly via hydrogen-bonding interactions. 
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Crystallization, data collection and processing
The protein endothiapepsin was purified from commercially available Suparen 600 by ultrafiltration using a cut-off of 10 kDa and repeated washing with 0.1 mol/l NaOAc buffer, pH= 4.6. After washing the protein concentration was adjusted to 5 mg/ml.
Crystals were obtained using sitting drop vapor-diffusion method with a drop volume of 4 µL, using streak-seeding with microcrystals. The conditions were 0.1 mol/L NaOAc, 0.1 mol/L NH4OAc, 50% PEG4000. Crystallization occurred within two days. Soaking of the ligand was achieved within 24 h in mother liquor containing additional 0.1 mol/L ligand and 25% glycerol.
Crystals were fished and flash-frozen in liquid nitrogen. Data was collected using an Incoatec 1 µm X-ray source equipped with an Oxford Cryosystems cryosystem and a Mar 345dtb image plate detector.
The structure was determined using molecular replacement and refined using ccp4i2 and phenix.refine. 
